Concepts (111)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Ultrasonography, Mammary | 14 | 2016 | 83 | 3.100 |
Why?
|
| Artificial Intelligence | 9 | 2023 | 332 | 2.370 |
Why?
|
| Breast Neoplasms | 27 | 2023 | 3022 | 2.340 |
Why?
|
| Diagnosis, Computer-Assisted | 8 | 2023 | 332 | 1.700 |
Why?
|
| Mammography | 6 | 2023 | 475 | 1.530 |
Why?
|
| Image Interpretation, Computer-Assisted | 10 | 2016 | 696 | 1.190 |
Why?
|
| Image Enhancement | 7 | 2018 | 565 | 1.130 |
Why?
|
| ROC Curve | 15 | 2018 | 778 | 1.040 |
Why?
|
| Algorithms | 10 | 2023 | 1913 | 0.930 |
Why?
|
| Breast Diseases | 2 | 2018 | 100 | 0.850 |
Why?
|
| Radiographic Image Interpretation, Computer-Assisted | 4 | 2023 | 474 | 0.830 |
Why?
|
| Machine Learning | 3 | 2023 | 270 | 0.820 |
Why?
|
| Pattern Recognition, Automated | 4 | 2010 | 221 | 0.820 |
Why?
|
| Radiology | 1 | 2023 | 202 | 0.730 |
Why?
|
| Breast | 4 | 2021 | 292 | 0.660 |
Why?
|
| Magnetic Resonance Imaging | 9 | 2023 | 3481 | 0.610 |
Why?
|
| Carcinoma, Ductal, Breast | 3 | 2015 | 160 | 0.600 |
Why?
|
| Diagnostic Imaging | 5 | 2023 | 476 | 0.550 |
Why?
|
| Axilla | 2 | 2014 | 103 | 0.530 |
Why?
|
| Sensitivity and Specificity | 11 | 2018 | 2018 | 0.520 |
Why?
|
| Lymph Nodes | 3 | 2015 | 550 | 0.510 |
Why?
|
| Lymphatic Metastasis | 2 | 2014 | 495 | 0.480 |
Why?
|
| Neoplasm Recurrence, Local | 2 | 2018 | 1355 | 0.470 |
Why?
|
| Radiography | 5 | 2023 | 808 | 0.420 |
Why?
|
| Female | 29 | 2023 | 46618 | 0.350 |
Why?
|
| Nonlinear Dynamics | 2 | 2010 | 73 | 0.350 |
Why?
|
| Models, Statistical | 3 | 2011 | 576 | 0.320 |
Why?
|
| Linear Models | 1 | 2009 | 422 | 0.310 |
Why?
|
| False Positive Reactions | 4 | 2014 | 223 | 0.300 |
Why?
|
| Humans | 35 | 2023 | 90014 | 0.300 |
Why?
|
| Image Processing, Computer-Assisted | 6 | 2018 | 1255 | 0.280 |
Why?
|
| User-Computer Interface | 1 | 2008 | 187 | 0.280 |
Why?
|
| Models, Theoretical | 1 | 2009 | 493 | 0.270 |
Why?
|
| Biopsy | 3 | 2018 | 1184 | 0.260 |
Why?
|
| Diagnosis, Differential | 4 | 2018 | 1606 | 0.260 |
Why?
|
| Reproducibility of Results | 8 | 2023 | 2770 | 0.250 |
Why?
|
| Ultrasonography | 2 | 2013 | 720 | 0.250 |
Why?
|
| Solitary Pulmonary Nodule | 1 | 2006 | 139 | 0.240 |
Why?
|
| Decision Making | 1 | 2009 | 671 | 0.220 |
Why?
|
| Computers | 1 | 2023 | 111 | 0.220 |
Why?
|
| Densitometry | 1 | 2003 | 29 | 0.220 |
Why?
|
| Patient Care | 1 | 2023 | 102 | 0.200 |
Why?
|
| Genomics | 2 | 2019 | 778 | 0.200 |
Why?
|
| Likelihood Functions | 2 | 2013 | 252 | 0.190 |
Why?
|
| Magnets | 1 | 2021 | 14 | 0.190 |
Why?
|
| Aged | 8 | 2019 | 19272 | 0.180 |
Why?
|
| Retrospective Studies | 8 | 2023 | 9237 | 0.180 |
Why?
|
| Area Under Curve | 3 | 2014 | 338 | 0.180 |
Why?
|
| Probability | 2 | 2014 | 351 | 0.180 |
Why?
|
| Middle Aged | 9 | 2018 | 26173 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2014 | 603 | 0.160 |
Why?
|
| Predictive Value of Tests | 3 | 2018 | 1732 | 0.160 |
Why?
|
| Prospective Studies | 2 | 2018 | 4329 | 0.150 |
Why?
|
| Computer Simulation | 3 | 2011 | 1102 | 0.140 |
Why?
|
| Tumor Burden | 1 | 2018 | 310 | 0.140 |
Why?
|
| Radiotherapy | 1 | 2018 | 332 | 0.140 |
Why?
|
| Adult | 7 | 2018 | 26836 | 0.130 |
Why?
|
| Disease-Free Survival | 1 | 2018 | 1169 | 0.120 |
Why?
|
| Carcinoma, Lobular | 1 | 2015 | 81 | 0.120 |
Why?
|
| Aged, 80 and over | 4 | 2018 | 6787 | 0.120 |
Why?
|
| Neoplasms | 2 | 2020 | 3067 | 0.110 |
Why?
|
| Observer Variation | 2 | 2013 | 614 | 0.110 |
Why?
|
| Automation | 1 | 2014 | 112 | 0.110 |
Why?
|
| Gene Expression Profiling | 1 | 2019 | 1452 | 0.110 |
Why?
|
| Mammary Glands, Human | 1 | 2013 | 24 | 0.110 |
Why?
|
| Lung Neoplasms | 1 | 2006 | 2370 | 0.110 |
Why?
|
| Breast Density | 1 | 2013 | 36 | 0.110 |
Why?
|
| Carcinoma | 1 | 2016 | 438 | 0.100 |
Why?
|
| Lipids | 1 | 2014 | 275 | 0.100 |
Why?
|
| Water | 1 | 2014 | 286 | 0.100 |
Why?
|
| Genome, Human | 1 | 2015 | 791 | 0.090 |
Why?
|
| Phenotype | 4 | 2019 | 2457 | 0.090 |
Why?
|
| Discriminant Analysis | 1 | 2009 | 67 | 0.080 |
Why?
|
| Documentation | 1 | 2010 | 103 | 0.080 |
Why?
|
| Prognosis | 2 | 2015 | 3800 | 0.080 |
Why?
|
| Confidence Intervals | 1 | 2009 | 221 | 0.080 |
Why?
|
| Fibrocystic Breast Disease | 1 | 2005 | 12 | 0.060 |
Why?
|
| Health Status Indicators | 1 | 2006 | 103 | 0.060 |
Why?
|
| Bayes Theorem | 2 | 2009 | 382 | 0.060 |
Why?
|
| Task Performance and Analysis | 1 | 2005 | 87 | 0.060 |
Why?
|
| Benchmarking | 1 | 2023 | 79 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2002 | 94 | 0.050 |
Why?
|
| Physics | 1 | 2021 | 21 | 0.050 |
Why?
|
| Hormones | 1 | 2021 | 139 | 0.050 |
Why?
|
| National Cancer Institute (U.S.) | 1 | 2020 | 72 | 0.040 |
Why?
|
| Adolescent | 2 | 2016 | 9347 | 0.040 |
Why?
|
| Signal-To-Noise Ratio | 1 | 2018 | 109 | 0.040 |
Why?
|
| Software | 1 | 2002 | 669 | 0.040 |
Why?
|
| Mass Screening | 1 | 2002 | 647 | 0.040 |
Why?
|
| United States | 3 | 2020 | 7114 | 0.040 |
Why?
|
| Artifacts | 1 | 2018 | 246 | 0.030 |
Why?
|
| Contrast Media | 1 | 2021 | 1084 | 0.030 |
Why?
|
| Radiotherapy Planning, Computer-Assisted | 1 | 1996 | 185 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 295 | 0.030 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 569 | 0.030 |
Why?
|
| Apoptosis | 1 | 2019 | 1718 | 0.030 |
Why?
|
| Early Detection of Cancer | 1 | 2016 | 422 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1309 | 0.020 |
Why?
|
| Transcription, Genetic | 1 | 2015 | 1158 | 0.020 |
Why?
|
| MicroRNAs | 1 | 2015 | 556 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2015 | 2000 | 0.020 |
Why?
|
| Republic of Korea | 1 | 2009 | 32 | 0.020 |
Why?
|
| Statistics, Nonparametric | 1 | 2009 | 305 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2016 | 2327 | 0.020 |
Why?
|
| Urban Population | 1 | 2009 | 225 | 0.020 |
Why?
|
| Biomarkers, Tumor | 1 | 2016 | 1545 | 0.020 |
Why?
|
| Mutation | 1 | 2015 | 4169 | 0.010 |
Why?
|
| Young Adult | 1 | 2016 | 6418 | 0.010 |
Why?
|
| Parotid Neoplasms | 1 | 1996 | 18 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1996 | 1747 | 0.000 |
Why?
|
| Male | 1 | 1996 | 42706 | 0.000 |
Why?
|